Neuropace Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Thank you everyone for joining us this afternoon for another session at the Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analysts here. From NeuroPace, it's my pleasure to have CEO, Mike Favet and CFO, Rebecca Kuhn with us here today for a fireside chat. Before we jump into that, just a brief disclaimer. For important disclosures, please see morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, Mike and Rebecca, thank you so much for taking the time here today. Looking forward to the discussion.
Thanks Drew, appreciate the opportunity.
Questions & Answers
And maybe first, just given that you are a newer company from a public perspective, just give us a brief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |